Randomized comparison of peptide immunization in patients at high risk for recurrence of melanoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interleukin-2; Melanoma vaccine; Montanide ISA-51
- Indications Malignant melanoma
- Focus Pharmacodynamics; Therapeutic Use
- 23 Oct 2012 Biomarkers information updated
- 16 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.